268 related articles for article (PubMed ID: 11579105)
21. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.
Nicoll G; Ni J; Liu D; Klenerman P; Munday J; Dubock S; Mattei MG; Crocker PR
J Biol Chem; 1999 Nov; 274(48):34089-95. PubMed ID: 10567377
[TBL] [Abstract][Full Text] [Related]
23. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice.
Brinkman-Van der Linden EC; Angata T; Reynolds SA; Powell LD; Hedrick SM; Varki A
Mol Cell Biol; 2003 Jun; 23(12):4199-206. PubMed ID: 12773563
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2.
Ulyanova T; Shah DD; Thomas ML
J Biol Chem; 2001 Apr; 276(17):14451-8. PubMed ID: 11278955
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.
Freeman S; Birrell HC; D'Alessio K; Erickson-Miller C; Kikly K; Camilleri P
Eur J Biochem; 2001 Mar; 268(5):1228-37. PubMed ID: 11231274
[TBL] [Abstract][Full Text] [Related]
26. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.
Cornish AL; Freeman S; Forbes G; Ni J; Zhang M; Cepeda M; Gentz R; Augustus M; Carter KC; Crocker PR
Blood; 1998 Sep; 92(6):2123-32. PubMed ID: 9731071
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.
Zhang J; Raper A; Sugita N; Hingorani R; Salio M; Palmowski MJ; Cerundolo V; Crocker PR
Blood; 2006 May; 107(9):3600-8. PubMed ID: 16397130
[TBL] [Abstract][Full Text] [Related]
28. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
29. Comparative genomics indicates the mammalian CD33rSiglec locus evolved by an ancient large-scale inverse duplication and suggests all Siglecs share a common ancestral region.
Cao H; de Bono B; Belov K; Wong ES; Trowsdale J; Barrow AD
Immunogenetics; 2009 May; 61(5):401-17. PubMed ID: 19337729
[TBL] [Abstract][Full Text] [Related]
30. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
Cao H; Crocker PR
Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
[TBL] [Abstract][Full Text] [Related]
31. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
[TBL] [Abstract][Full Text] [Related]
32. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils.
Zhang M; Angata T; Cho JY; Miller M; Broide DH; Varki A
Blood; 2007 May; 109(10):4280-7. PubMed ID: 17272508
[TBL] [Abstract][Full Text] [Related]
33. A second uniquely human mutation affecting sialic acid biology.
Angata T; Varki NM; Varki A
J Biol Chem; 2001 Oct; 276(43):40282-7. PubMed ID: 11546777
[TBL] [Abstract][Full Text] [Related]
34. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.
Munday J; Kerr S; Ni J; Cornish AL; Zhang JQ; Nicoll G; Floyd H; Mattei MG; Moore P; Liu D; Crocker PR
Biochem J; 2001 Apr; 355(Pt 2):489-97. PubMed ID: 11284738
[TBL] [Abstract][Full Text] [Related]
35. Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein.
Nordström T; Movert E; Olin AI; Ali SR; Nizet V; Varki A; Areschoug T
J Biol Chem; 2011 Sep; 286(39):33981-91. PubMed ID: 21795693
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
37. A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor.
Sonnenburg JL; Altheide TK; Varki A
Glycobiology; 2004 Apr; 14(4):339-46. PubMed ID: 14693915
[TBL] [Abstract][Full Text] [Related]
38. Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides.
Rapoport EM; Pazynina GV; Sablina MA; Crocker PR; Bovin NV
Biochemistry (Mosc); 2006 May; 71(5):496-504. PubMed ID: 16732727
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.
Yu Z; Lai CM; Maoui M; Banville D; Shen SH
J Biol Chem; 2001 Jun; 276(26):23816-24. PubMed ID: 11328818
[TBL] [Abstract][Full Text] [Related]
40. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
